Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference Life Science Investing
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option Life Science Investing
Aquestive Therapeutics to Present New Clinical Data on Anaphylm Sublingual Film at the 2026 AAAAI Annual Meeting Pharmaceutical Investing
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference Medical Device Investing
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors Life Science Investing
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors Life Science Investing
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th Life Science Investing
U.S. Food and Drug Administration Approves Combination Treatment of VENCLEXTA® and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia Pharmaceutical Investing
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026 Life Science Investing
